Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.87% | -16.60% | -9.74% | -9.39% | -4.52% |
| Total Depreciation and Amortization | -45.45% | -55.31% | -55.42% | -40.33% | -24.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.10% | 82.41% | -758.46% | -1,008.47% | -1,569.23% |
| Change in Net Operating Assets | -361.99% | -673.82% | 51.16% | 39.45% | 67.31% |
| Cash from Operations | -32.09% | -33.44% | -23.88% | -19.94% | -10.31% |
| Capital Expenditure | 36.57% | 64.01% | 47.02% | 43.49% | -0.49% |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.83% | 67.45% | 50.77% | 46.54% | 5.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.13% | 233.33% | 57.26% | 83.62% | 9.09% |
| Repurchase of Common Stock | -575.55% | -- | -- | -- | -19.84% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.63% | 0.51% | -0.73% | -1.63% | -1.61% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -239.39% | -472.34% | -327.55% | -231.06% | -8.35% |
| Foreign Exchange rate Adjustments | 78.57% | -299.71% | -30.15% | -829.03% | 93.01% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.29% | -155.52% | -98.70% | -74.99% | -14.25% |